Food companies face a July 2028 deadline to comply with the FDA’s FSMA 204 traceability rule. Our latest research sees an opportunity in low-cost tools for small and mid-size businesses. https://t.co/vkTcUkWLwK
SaaS stocks continued their recovery in the September quarter, with our universe gaining 23.8% versus 2.0% for the S&P 500. Our latest SaaS Quarterly insight tracks valuations, M&A and private placements. https://t.co/rTXHEc1lWl
Electrification and AI data centers are straining grids, and the value of electrical submetering has surged. Our latest research explains why the market is poised for growth and profiles 9 participants. https://t.co/ti6x34HH5s
We're pleased to share that First Analysis was the exclusive financial advisor to Phigenics on its majority growth investment from BatteryVentures, bringing a leading technology investor to its healthcare-focused water risk management platform. https://t.co/tr3SkYeABn
CDISC maturity is becoming a clear signal of #pharmaIT vendors' competitive strength and enterprise value. Our latest #eClinical report profiles six vendors helping sponsors implement it. https://t.co/PmmKPwctSR
SaaS stocks partially rebounded in the June quarter, with our universe gaining 18.9% versus 14.9% for the S&P 500. In our latest #SaaS quarterly, we examine valuations, AI's impact and SaaS M&A and private placement activity. https://t.co/QHCP8ipbFG
AI adoption in supply chains is still early, but practical use cases are emerging. Our latest research maps 5 areas gaining traction: continuous monitoring, data synthesis, AI agents, end-to-end visibility and digital twins. https://t.co/fX2yiD5K2X
In our latest report, Howard Smith and Liam Moran examine four debates that framed the #cybersecurity conversation at RSA 2026, from AI security risks and AI-enabled attackers to the outlook for cybersecurity vendors. https://t.co/hsvDBQ6m6U
After more than a decade of publishing on the #IoT sector, we see a more open capital environment taking shape for a broader range of companies and business models.
Read more: https://t.co/yHBdF6noa4
First Analysis portfolio company Dina has been acquired by Integrated Home Care Services, combining AI-enabled care coordination with in-home benefit management expertise to support more effective, simple and affordable homecare. https://t.co/WXeFrYciSt
Read our latest #HealthcareTech report examining how healthcare is finally learning to use the clinical data it has — and the four-layer infrastructure stack making it possible. https://t.co/uIXTdzGNNu
New report: Our SaaS universe stocks declined 24.1% on average in the March quarter, significantly underperforming the S&P 500’s 4.6% loss. Recent growth and near-term growth outlook seem to reflect little negative impact from the AI transition. https://t.co/dqa3ZuDSlW
First Analysis portfolio company Bindplane, developer of observability tools built on OpenTelemetry, has been acquired by Dynatrace. We’re proud to have partnered with the company and pleased to see it enter this next phase. https://t.co/S1ozK2Os3p
New healthcare tech report from Andrew Walsh and Kenny Guerrero: #PBM reform is reshaping the prescription drug value chain, with a new landscape emerging defined by transparency, decisions driven by data and the unbundling of pharmacy benefit services. https://t.co/XThDbODLFJ
Supply chains are complex, fragile and under more pressure than ever. Our latest report examines why avoiding change is no longer an option — and the technologies helping stakeholders build resilience through diversification. https://t.co/ky4UMtvQIr
Read our annual analysis of publicly traded, enterprise‑focused #cybersecurity company performance that breaks down the disconnect between aggregate revenue growth and median stock decline. https://t.co/X9vDcJByMd
Global supply chains are becoming more complex, more digital, more exposed to disruption, yet many enterprises rely on systems built for a different era. Building on years of logistics experience, we've launched a dedicated supply chain research sector:
https://t.co/8G6yEpkiYk
The First Analysis Healthcare Technology Summit and SCOPE highlight five themes shaping pharma IT - disciplined transaction activity, infrastructure-driven platforms, embedded AI, continued focus on RWE and rising demand for compliant, audit-ready systems.
https://t.co/oSjLA8e9bi
New investment: First Analysis led a financing in TPN health, a behavioral health platform enabling scalable care navigation, accurate provider networks and seamless connectivity. Read the full announcement: https://t.co/RjP24HL5Ur
Healthcare is being pushed to do more with less. Read our key takeaways from our Healthcare IT Panel on the forces reshaping healthcare delivery - and why #dataliquidity, true #interoperability, and #responsibleAI adoption are becoming critical. https://t.co/qp5wlKcoiN